Early detection of neonatal disorders is paramount for effective treatment and improving outcomes. Screening programs, such as newborn blood spot tests, can identify conditions like phenylketonuria (PKU), congenital hypothyroidism, and cystic fibrosis. These tests enable healthcare providers to initiate early interventions, which can significantly reduce the risk of complications and improve long-term health.